Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Reduction Effect of Oral Pravastatin on Acute Phase Response of Intravenous Zoledronic Acid: a Real-world Study

NCT04719481 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT04719481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04719481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Reduction Effect of Oral Pravastatin on Acute Phase Response of Intravenous Zoledronic Acid: a Real-world Study
Lead sponsor
Peking University Third Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2021
Completion date
April 30, 2022
Enrollment
110 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal osteoporosis